Fort Lee, NJ, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Herborium® Group,
Inc. (OTC Pink: HBRM),
www.Herborium.com, a
Botanical Therapeutics® Company and the provider of unique
all botanical medicines (Botanical Therapeutics®)
announced today that HUT Group, LLC. , the UK's leading
multi-website online retailer of Health and Beauty products is
expending the marketing and sales of AcnEase®, Herborium's unique
acne treatment on its leading platforms with a goal of
£500,000.00 ($785,000.00) in sales within next 18-24
months. Hut will also introduce Herborium' women, men and energy
products in the European market in 2015.
The Hut Group is one of Europe's fastest growing online
lifestyle and health & and beauty destinations. It is
currently the UK's leading multi-website online retailer with
rapidly growing global operations including a significant growth in
Asia. Hut supports more than 140 million global website visitors, 5
million customers and 8 million orders dispatched worldwide across
such on line stores as www.myprotein.com, www.LookFantastic.com,
www.beautyexpert.co.uk,
mankind.co.uk, www.coggles.com and others.
"We are very excited about the expansion of marketing and sales
of AcnEase® and introduction of other Herborium products on Hut
unique end to end technology platform. With potential for a million
pageviews daily our Botanical Therapeutics® will reach millions of
customers in Europe and Asia. We are expecting Hut's goal for
£500 thousand in sales of AcnEase® to be just a beginning of
new growth opportunities" commented Dr. Agnes P. Olszewski, CEO and
Chairwoman of Herborium.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that
develops, license and markets proprietary, botanical based
medicinal products to consumers and healthcare professionals. The
Company business model focuses on emerging market opportunities
spearheaded by the growth of a new market sector located between
high-cost, high-risk, ethical pharmaceuticals and commoditized
classic nutraceuticals (supplements). The Company uses
clinical validation and a proactive regulatory strategy based on
the FDA Guidance for Industry: Botanical Drug Products
(FDA Guidance 2004) to establish and maintain a
differential advantage. Herborium has secured a pipeline of
botanical ingredients based products in the areas of dermatological
needs, wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants, diabetes, surgical procedures, and other
problems. Herborium Group sells its products in the United States,
the United Kingdom, and continental Europe through a network of
distributors, specialty retailers, and e-commerce. For more
information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains
forward-looking statements with respect to the results of
operations and business of Sunrise Consulting Group, Inc., which
involves risks and uncertainties. The Company's actual future
results could materially differ from those discussed.
The Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of
1995.
CONTACT: Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com